Does tremfya have a biosimilar?

As of June 2024, Tremfya (guselkumab) does not have an FDA- or EMA-approved biosimilar. Several companies have explored guselkumab biosimilars, and a few may have reached late-stage development or regulatory review, but none are approved yet.

If you’d like, I can check the most current status for you. Just tell me the country or region you’re in.

Note: If you’re considering treatment changes, discuss with your doctor. Biosimilar options for other therapies (like adalimumab biosimilars) exist, but they aren’t interchangeable with guselkumab.